NH News

Kadmon (KDMN) raised $75 million (53% insider) on its IPO and proceeded to drop 19% on Wednesday, the year's second-worst debut. Kadmon is only the latest in a string of biotech IPOs that have disappointed. Of the 12 biotechs that have IPO'd since the second quarter began, 10 currently trade below issue (82%) and the group's average return is -15%, mirroring the...read more

The shortened holiday week saw three healthcare IPOs raise over $150 million, bringing the year-to-date total up to 34 offerings. Can't stop Nant: NantHealth surges 33% in year's second-best IPO debut Billionaire founder and CEO Patrick Soon-Shiong became even richer, as NantHealth (NH) raised $91 million and popped 33% on its debut....read more

NantHealth, which provides healthcare data solutions and plans to launch a new cancer diagnostic, raised $91 million by offering 6.5 million shares at $14, the midpoint of the range of $12.50 to $15.50. Existing shareholders, including CEO Patrick Soon-Shiong and Celgene (Nasdaq: CELG), had indicated an interest in purchasing up to $70 million (77%) of the IPO. NantHealth...read more

The shortened holiday week ahead will see two deals come to market, raising just over $100 million combined. Coming off 15 pricings in May, the seasonally strong June should see similar or improved market activity.  ...read more